Cargando…

COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy

BACKGROUND: COVID-19 in Italy has led to the need to reorganize hospital protocols with a significant risk of interruption to cancer treatment programs. In this report, we will focus on a management model covering the two phases of the COVID-19 emergency, namely lockdown-phase I and post-lockdown-ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Caravatta, Luciana, Rosa, Consuelo, Di Sciascio, Maria Bernadette, Tavella Scaringi, Andrea, Di Pilla, Angelo, Ursini, Lucia Anna, Taraborrelli, Maria, Vinciguerra, Annamaria, Augurio, Antonietta, Di Tommaso, Monica, Trignani, Marianna, Nuzzo, Marianna, Falco, Maria Daniela, De Nicola, Andrea, Adorante, Nico, Patani, Fabiola, Centofanti, Giuseppe, Gasparini, Lucrezia, Fasciolo, David, Di Guglielmo, Fiorella Cristina, Bonfiglio, Cecilia, Borgia, Marzia, Caravaggio, Gabriella, Marcucci, Stefano, Turchi, Consalvo, Mancinelli, Domenico, Sartori, Stephanie, Schael, Thomas, Muraglia, Angelo, Caputi, Sergio, D’Amario, Claudio, Verì, Nicoletta, Genovesi, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522911/
https://www.ncbi.nlm.nih.gov/pubmed/32993690
http://dx.doi.org/10.1186/s13014-020-01670-9
_version_ 1783588284760326144
author Caravatta, Luciana
Rosa, Consuelo
Di Sciascio, Maria Bernadette
Tavella Scaringi, Andrea
Di Pilla, Angelo
Ursini, Lucia Anna
Taraborrelli, Maria
Vinciguerra, Annamaria
Augurio, Antonietta
Di Tommaso, Monica
Trignani, Marianna
Nuzzo, Marianna
Falco, Maria Daniela
De Nicola, Andrea
Adorante, Nico
Patani, Fabiola
Centofanti, Giuseppe
Gasparini, Lucrezia
Fasciolo, David
Di Guglielmo, Fiorella Cristina
Bonfiglio, Cecilia
Borgia, Marzia
Caravaggio, Gabriella
Marcucci, Stefano
Turchi, Consalvo
Mancinelli, Domenico
Sartori, Stephanie
Schael, Thomas
Muraglia, Angelo
Caputi, Sergio
D’Amario, Claudio
Verì, Nicoletta
Genovesi, Domenico
author_facet Caravatta, Luciana
Rosa, Consuelo
Di Sciascio, Maria Bernadette
Tavella Scaringi, Andrea
Di Pilla, Angelo
Ursini, Lucia Anna
Taraborrelli, Maria
Vinciguerra, Annamaria
Augurio, Antonietta
Di Tommaso, Monica
Trignani, Marianna
Nuzzo, Marianna
Falco, Maria Daniela
De Nicola, Andrea
Adorante, Nico
Patani, Fabiola
Centofanti, Giuseppe
Gasparini, Lucrezia
Fasciolo, David
Di Guglielmo, Fiorella Cristina
Bonfiglio, Cecilia
Borgia, Marzia
Caravaggio, Gabriella
Marcucci, Stefano
Turchi, Consalvo
Mancinelli, Domenico
Sartori, Stephanie
Schael, Thomas
Muraglia, Angelo
Caputi, Sergio
D’Amario, Claudio
Verì, Nicoletta
Genovesi, Domenico
author_sort Caravatta, Luciana
collection PubMed
description BACKGROUND: COVID-19 in Italy has led to the need to reorganize hospital protocols with a significant risk of interruption to cancer treatment programs. In this report, we will focus on a management model covering the two phases of the COVID-19 emergency, namely lockdown-phase I and post-lockdown-phase II. METHODS: The following steps were taken in the two phases: workload during visits and radiotherapy planning, use of dedicated routes, measures for triage areas, management of suspected and positive COVID-19 cases, personal protective equipment, hospital environments and intra-institutional meetings and tumor board management. Due to the guidelines set out by the Ministry of Health, oncological follow-up visits were interrupted during the lockdown-phase I; consequently, we set about contacting patients by telephone, with laboratory and instrumental exams being viewed via telematics. During the post-lockdown-phase II, the oncological follow-up clinic reopened, with two shifts operating daily. RESULTS: By comparing our radiotherapy activity from March 9 to May 4 2019 with the same period in 2020 during full phase I of the COVID-19 emergency, similar results were achieved. First radiotherapy visits, Simulation Computed Tomography and Linear Accelerator treatments amounted to 123, 137 and 151 in 2019 compared with 121, 135 and 170 in 2020 respectively. There were no cases of COVID-19 positivity recorded either in patients or in healthcare professionals, who were all negative to the swab tests performed. CONCLUSION: During both phases of the COVID-19 emergency, the planned model used in our own experience guaranteed both continuity in radiotherapy treatments whilst neither reducing workload nor interrupting treatment and, as such, it ensured the safety of cancer patients, hospital environments and staff.
format Online
Article
Text
id pubmed-7522911
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75229112020-09-29 COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy Caravatta, Luciana Rosa, Consuelo Di Sciascio, Maria Bernadette Tavella Scaringi, Andrea Di Pilla, Angelo Ursini, Lucia Anna Taraborrelli, Maria Vinciguerra, Annamaria Augurio, Antonietta Di Tommaso, Monica Trignani, Marianna Nuzzo, Marianna Falco, Maria Daniela De Nicola, Andrea Adorante, Nico Patani, Fabiola Centofanti, Giuseppe Gasparini, Lucrezia Fasciolo, David Di Guglielmo, Fiorella Cristina Bonfiglio, Cecilia Borgia, Marzia Caravaggio, Gabriella Marcucci, Stefano Turchi, Consalvo Mancinelli, Domenico Sartori, Stephanie Schael, Thomas Muraglia, Angelo Caputi, Sergio D’Amario, Claudio Verì, Nicoletta Genovesi, Domenico Radiat Oncol Research BACKGROUND: COVID-19 in Italy has led to the need to reorganize hospital protocols with a significant risk of interruption to cancer treatment programs. In this report, we will focus on a management model covering the two phases of the COVID-19 emergency, namely lockdown-phase I and post-lockdown-phase II. METHODS: The following steps were taken in the two phases: workload during visits and radiotherapy planning, use of dedicated routes, measures for triage areas, management of suspected and positive COVID-19 cases, personal protective equipment, hospital environments and intra-institutional meetings and tumor board management. Due to the guidelines set out by the Ministry of Health, oncological follow-up visits were interrupted during the lockdown-phase I; consequently, we set about contacting patients by telephone, with laboratory and instrumental exams being viewed via telematics. During the post-lockdown-phase II, the oncological follow-up clinic reopened, with two shifts operating daily. RESULTS: By comparing our radiotherapy activity from March 9 to May 4 2019 with the same period in 2020 during full phase I of the COVID-19 emergency, similar results were achieved. First radiotherapy visits, Simulation Computed Tomography and Linear Accelerator treatments amounted to 123, 137 and 151 in 2019 compared with 121, 135 and 170 in 2020 respectively. There were no cases of COVID-19 positivity recorded either in patients or in healthcare professionals, who were all negative to the swab tests performed. CONCLUSION: During both phases of the COVID-19 emergency, the planned model used in our own experience guaranteed both continuity in radiotherapy treatments whilst neither reducing workload nor interrupting treatment and, as such, it ensured the safety of cancer patients, hospital environments and staff. BioMed Central 2020-09-29 /pmc/articles/PMC7522911/ /pubmed/32993690 http://dx.doi.org/10.1186/s13014-020-01670-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Caravatta, Luciana
Rosa, Consuelo
Di Sciascio, Maria Bernadette
Tavella Scaringi, Andrea
Di Pilla, Angelo
Ursini, Lucia Anna
Taraborrelli, Maria
Vinciguerra, Annamaria
Augurio, Antonietta
Di Tommaso, Monica
Trignani, Marianna
Nuzzo, Marianna
Falco, Maria Daniela
De Nicola, Andrea
Adorante, Nico
Patani, Fabiola
Centofanti, Giuseppe
Gasparini, Lucrezia
Fasciolo, David
Di Guglielmo, Fiorella Cristina
Bonfiglio, Cecilia
Borgia, Marzia
Caravaggio, Gabriella
Marcucci, Stefano
Turchi, Consalvo
Mancinelli, Domenico
Sartori, Stephanie
Schael, Thomas
Muraglia, Angelo
Caputi, Sergio
D’Amario, Claudio
Verì, Nicoletta
Genovesi, Domenico
COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy
title COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy
title_full COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy
title_fullStr COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy
title_full_unstemmed COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy
title_short COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy
title_sort covid-19 and radiation oncology: the experience of a two-phase plan within a single institution in central italy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522911/
https://www.ncbi.nlm.nih.gov/pubmed/32993690
http://dx.doi.org/10.1186/s13014-020-01670-9
work_keys_str_mv AT caravattaluciana covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT rosaconsuelo covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT disciasciomariabernadette covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT tavellascaringiandrea covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT dipillaangelo covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT ursiniluciaanna covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT taraborrellimaria covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT vinciguerraannamaria covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT augurioantonietta covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT ditommasomonica covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT trignanimarianna covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT nuzzomarianna covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT falcomariadaniela covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT denicolaandrea covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT adorantenico covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT patanifabiola covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT centofantigiuseppe covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT gasparinilucrezia covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT fasciolodavid covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT diguglielmofiorellacristina covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT bonfigliocecilia covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT borgiamarzia covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT caravaggiogabriella covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT marcuccistefano covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT turchiconsalvo covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT mancinellidomenico covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT sartoristephanie covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT schaelthomas covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT muragliaangelo covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT caputisergio covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT damarioclaudio covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT verinicoletta covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly
AT genovesidomenico covid19andradiationoncologytheexperienceofatwophaseplanwithinasingleinstitutionincentralitaly